Targanta Therapeutics to Present at November 2008 Investor Conferences

  
    
  
  
    
      Targanta Therapeutics Corporation (Nasdaq: TARG) today announced its 
      planned participation in the following investor conferences in November 
      2008:
    
    
      
        Rodman and Renshaw 10th Annual Healthcare 
        Conference on Tuesday, November 11, 2008 at 5:45p.m. ET at the New 
        York Palace Hotel in New York, NY.
      
      
        Credit Suisse 2008 Healthcare Conference on Friday, November 14, 2008 
        at 12:00p.m. ET at the Arizona Biltmore in Phoenix, AZ.
      
      
        Lazard Capital Markets 5th Annual Healthcare 
        Conference on Tuesday, November 18, 2008 at 2:40p.m. ET at the St. 
        Regis Hotel in New York, NY.
      
    
    
      The presentations will be webcast live and will be available for replay 
      for approximately 30 days following the presentations through the 
      Investor Relations section of Targanta’s 
      website at www.targanta.com/investors.
    
    
      About Targanta Therapeutics
    
    
      Targanta Therapeutics Corporation (Nasdaq: TARG) is a biopharmaceutical 
      company focused on developing and commercializing innovative antibiotics 
      to treat serious infections in the hospital and other institutional 
      settings. The Company’s pipeline includes an 
      intravenous version of oritavancin, a semi-synthetic lipoglycopeptide 
      antibiotic currently awaiting U.S. and EU regulatory approval, and, a 
      program to develop an oral version of oritavancin for the treatment of Clostridium 
      difficile. The Company has operations in Cambridge, MA, 
      Indianapolis, IN, and Montreal, Québec, 
      Canada. For more information on Targanta, visit www.targanta.com.